Adel Naimi

905 total citations · 1 hit paper
15 papers, 643 citations indexed

About

Adel Naimi is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Adel Naimi has authored 15 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Adel Naimi's work include Cell death mechanisms and regulation (5 papers), Mesenchymal stem cell research (4 papers) and RNA Interference and Gene Delivery (3 papers). Adel Naimi is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Mesenchymal stem cell research (4 papers) and RNA Interference and Gene Delivery (3 papers). Adel Naimi collaborates with scholars based in Iran, Iraq and Egypt. Adel Naimi's co-authors include Ali Hassanzadeh, Wanich Suksatan, Alexei Valerievich Yumashev, Lakshmi Thangavelu, Ahmed Raji, Ehsan Razeghian, Mohammed Nader Shalaby, Ali Noroozi‐Aghideh, Supat Chupradit and Rebar N. Mohammed and has published in prestigious journals such as Journal of Cellular Physiology, Biomedicine & Pharmacotherapy and Stem Cell Research & Therapy.

In The Last Decade

Adel Naimi

15 papers receiving 638 citations

Hit Papers

Tumor immunotherapies by immune checkpoint inhibitors (IC... 2022 2026 2023 2024 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
    2022 306 citations Adel Naimi, Rebar N. Mohammed et al. Cell Communication and Signaling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adel Naimi Iran 10 291 226 199 76 73 15 643
Dongsheng Xu China 14 435 1.5× 203 0.9× 363 1.8× 128 1.7× 44 0.6× 24 841
Ali Adili Iran 11 260 0.9× 209 0.9× 164 0.8× 86 1.1× 16 0.2× 29 563
Erin E. Childs United States 10 192 0.7× 243 1.1× 246 1.2× 50 0.7× 24 0.3× 12 648
Christian Bryant Australia 15 400 1.4× 265 1.2× 452 2.3× 29 0.4× 81 1.1× 36 992
Bin Qiao China 18 353 1.2× 408 1.8× 125 0.6× 90 1.2× 25 0.3× 36 874
Ryo Sato Japan 11 289 1.0× 283 1.3× 65 0.3× 115 1.5× 26 0.4× 22 572
Meng Lu China 16 325 1.1× 481 2.1× 322 1.6× 117 1.5× 24 0.3× 36 988
Guorong Hu China 10 193 0.7× 175 0.8× 192 1.0× 83 1.1× 11 0.2× 13 605

Countries citing papers authored by Adel Naimi

Since Specialization
Citations

This map shows the geographic impact of Adel Naimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Naimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Naimi more than expected).

Fields of papers citing papers by Adel Naimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Naimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Naimi. The network helps show where Adel Naimi may publish in the future.

Co-authorship network of co-authors of Adel Naimi

This figure shows the co-authorship network connecting the top 25 collaborators of Adel Naimi. A scholar is included among the top collaborators of Adel Naimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel Naimi. Adel Naimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Naimi, Adel, Rebar N. Mohammed, Ahmed Raji, et al.. (2022). Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Communication and Signaling. 20(1). 44–44. 306 indexed citations breakdown →
2.
Naimi, Adel, et al.. (2022). Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis. Journal of Clinical Laboratory Analysis. 36(5). e24387–e24387. 19 indexed citations
3.
Noroozi‐Aghideh, Ali, et al.. (2021). Quercetin elicits proapoptotic effect through downregulation of antiapoptotic and upregulation of proapoptotic genes in human myeloid leukemia KG-1 cells. Annals of Cancer Research and Therapy. 29(1). 96–101. 2 indexed citations
4.
Rahman, Heshu Sulaiman, Masoud Soleimani, Mohammad Asghari Jafarabadi, et al.. (2021). Kaempferol sensitizes tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous leukemia cells to apoptosis. Molecular Biology Reports. 49(1). 19–29. 9 indexed citations
5.
Naimi, Adel, et al.. (2021). Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review. Frontiers in Medicine. 8. 740593–740593. 32 indexed citations
6.
Marofi, Faroogh, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, et al.. (2021). CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies. Stem Cell Research & Therapy. 12(1). 374–374. 56 indexed citations
7.
8.
Tavakoli, Shirin, et al.. (2020). Mesenchymal stromal cells; a new horizon in regenerative medicine. Journal of Cellular Physiology. 235(12). 9185–9210. 65 indexed citations
9.
Naimi, Adel, et al.. (2020). Knockdown of Enhancer of Zeste Homolog 2 Affects mRNA Expression of Genes Involved in the Induction of Resistance to Apoptosis in MOLT-4 Cells. Anti-Cancer Agents in Medicinal Chemistry. 20(5). 571–579. 3 indexed citations
10.
Zamani, Majid, Yoda Yaghoubi, Adel Naimi, et al.. (2020). Humanized Culture Medium for Clinical-grade Generation of Erythroid Cells from Umbilical Cord Blood CD34+ Cells. Advanced Pharmaceutical Bulletin. 11(2). 335–342. 9 indexed citations
11.
Yaghoubi, Yoda, Majid Zamani, Adel Naimi, et al.. (2020). Human CD34+ hematopoietic stem cells culture in humanized culture medium for cell therapy. Gene Reports. 20. 100718–100718. 6 indexed citations
12.
Hassanzadeh, Ali, et al.. (2019). Kaempferol Improves TRAIL-Mediated Apoptosis in Leukemia MOLT-4 Cells by the Inhibition of Anti-apoptotic Proteins and Promotion of Death Receptors Expression. Anti-Cancer Agents in Medicinal Chemistry. 19(15). 1835–1845. 19 indexed citations
13.
Naimi, Adel, et al.. (2018). Quercetin sensitizes human myeloid leukemia KG‐1 cells against TRAIL‐induced apoptosis. Journal of Cellular Physiology. 234(8). 13233–13241. 37 indexed citations
14.
Marofi, Faroogh, et al.. (2018). Leukemia therapy by flavonoids: Future and involved mechanisms. Journal of Cellular Physiology. 234(6). 8203–8220. 36 indexed citations
15.
Naimi, Adel, Ali Akbar Movassaghpour, Majid Farshdousti Hagh, et al.. (2017). TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies. Biomedicine & Pharmacotherapy. 98. 566–576. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongsheng Xu Breakdown of academic impact, for papers by Ali Adili Breakdown of academic impact, for papers by Erin E. Childs Breakdown of academic impact, for papers by Christian Bryant Breakdown of academic impact, for papers by Bin Qiao Breakdown of academic impact, for papers by Ryo Sato Breakdown of academic impact, for papers by Meng Lu Breakdown of academic impact, for papers by Guorong Hu
Rankless by CCL
2026